Cipla Quality Chemical Industries Ltd

Companies

Cipla Quality Chemical Industries drops Cipla as part of name change

Cipla sold its stake in the drugmaker last November to Africa Capitalworks SSA 3, a Mauritius-based investment vehicle controlled by a South African equity fund
The pharmaceutical manufacturing plant of Quality Chemical Industries Ltd in Luzira, Kampala. The company manufactures and sells antiretroviral medicines for HIV/AIDS, artemisinin-based combination therapies for malaria and hepatitis B medicines using technology from Cipla Limited. Cipla, the Indian pharmaceutical giant, sold its stake in the drugmaker in November last year to Africa Capitalworks SSA 3, a Mauritius-based investment vehicle ultimately controlled by South African private equity fund Capitalworks Group, for $25mn (Shs94.2bn).
CompaniesCorporate earnings and results

Cipla Quality Chemical Industries first-half profit falls on rising expenses

Cipla Quality Chemical Industries posted a 74.3 per cent fall in its net profit for the six months to September 2023, despite growth in sales, as expenses increased
Exterior of Cipla Quality Chemical Industries head offices in Kampala
CompaniesMergers & Acquisitions

Quality Chemical Industries gets new owner as Cipla exits

Africa Capitalworks SSA 3, an investment vehicle based in Mauritius, is the new majority shareholder of the pharmaceutical company
A group of men on a guided tour, directed by another man, in a pharmaceuticals factory
CompaniesCorporate earnings and resultsMarkets

Cipla Quality Chemicals warns 1H profit to drop

Drug maker says last year's rise in profit for the same period was the result of the recovery of a previously written-off trade receivable
Exterior of Cipla Quality Chemical Industries head offices in Kampala
CompaniesCorporate earnings and resultsMarkets

Cipla Quality Chemicals posts loss as exports decline

Cipla Quality Chemical's exports fell sharply, largely as a result of suspending sales to the government of Zambia following delayed payments, leading to a decline in revenue and the company's first loss since listing in 2018
CIPLA Quality Chemicals Offices
CompaniesMarkets

Cipla Quality Chemicals faces loss on Zambia debt

The drugmaker Cipla Quality Chemical Industries Limited faces a net operating loss for the year to March 2020 after a delay in payment of debt owed by the Zambian government, the company said in a profit warning
Antiretroviral drugs to treat HIV infection
CompaniesCorporate earnings and resultsMarkets

Cipla Quality Chemical profits plunge in first full-year results

Cipla Quality Chemical Industries Limited, the drugmaker controlled by the Indian pharmaceutical giant Cipla Limited, reported a 14.2% fall in revenue for its first full-year results announcement since listing
CIPLA Quality Chemicals Offices
CompaniesMarkets

Cipla Quality Chemicals to list on Uganda Securities Exchange in September

Cipla Quality Chemical Industries Limited, controlled by the Indian pharmaceutical giant Cipla Limited, will become the eighth domestic company to list on the Uganda Securities Exchange next month, according to a preliminary prospectus
CIPLA Quality Chemicals Offices
Companies

Cipla Quality Chemical Industries to list 31.1% stake in IPO — report

Cipla Quality Chemical Industries Limited, the drugmaker, will list 31.1% of its stock on the Uganda Securities Exchange in its initial public offering, which is still awaiting the regulator's approval.
CIPLA Quality Chemicals Offices
CompaniesTop 100 Taxpayers

Company profile: Cipla Quality Chemicals Industries Ltd

The drugmaker was established in 2005 as a joint venture between Cipla Limited and Ugandan businessmen. In a government-brokered partnership, Cipla Ltd - one of the world’s leading pharmaceutical manufacturers - joined with a local firm, Quality Chemicals Ltd (QCL), to manufacture antiretroviral and antimalarial drugs locally.
CIPLA Quality Chemicals Offices
12Next